✦ LIBER ✦

A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Scribed by Tony S. K. Mok; Benny Zee; Anthony T. C. Chan; Winnie Yeo; Wei Tse Yang; Anthony Yim; Sing Fai Leung; Binh Nguyen; Thomas W. T. Leung; Philip Johnson

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 95 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20000801)89:3<543::aid-cncr9>3.0.co;2-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose tamoxifen plus cisplatin and e

High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma

✍ Chih-Hsin Yang; Ann-Lii Cheng; Kun-Huei Yeh; Chong-Jen Yu; Jing-Fang Lin; Pan-Ch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

## BACKGROUND. Tamoxifen sensitizes cancer cells to chemotherapeutic agents. High dose tamoxifen has been tested in the treatment of patients with melanoma and other cancers. The authors conducted a Phase II study of high dose tamoxifen plus cisplatin and etoposide for patients with advanced, inop

Treatment of patients with advanced nons

Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor

✍ Michael Hejna; Gabriela V. Kornek; Markus Raderer; Herbert Ulrich-Pur; Wolfgang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

UFT plus cisplatin combination chemother

UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma : A multiinstitutional Phase II trial

✍ Yukito Ichinose; Kozo Yosimori; Shuichi Yoneda; Mutsuo Kuba; Shoji Kudoh; Hisano 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Background: Combination chemotherapy comprised of oral uft (a combination of tegafur and uracil) and cisplatin was shown to be an effective regimen for the treatment of advanced nonsmall cell lung carcinoma and to be associated with a low incidence rate of toxicity in a previous, single institut

Phase II study of gemcitabine and cispla

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

✍ Philip A. Philip; Mark M. Zalupski; V. K. Vaitkevicius; Patricia Arlauskas; Ruth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Phase I/II trial of paclitaxel by 1-hour

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ John D. Hainsworth; Howard A. Burris III; Joan B. Erland; Lisa H. Morrissey; Ant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## BACKGROUND. The combination of paclitaxel and carboplatin is widely used in the treatment of patients with advanced nonsmall cell lung carcinoma. In this Phase I/II study the authors evaluated the feasibility, toxicity, and efficacy of adding a third active antineoplastic agent, gemcitabine, to

A Phase II study of paclitaxel-ifosfamid

A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

✍ Christos Kosmas; Nicolas B. Tsavaris; Aristidis Polyzos; Haralambos P. Kalofonos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views